Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Cognition, reserve, and amyloid deposition in normal aging.

Rentz DM, Locascio JJ, Becker JA, Moran EK, Eng E, Buckner RL, Sperling RA, Johnson KA.

Ann Neurol. 2010 Mar;67(3):353-64. doi: 10.1002/ana.21904.

2.

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, Masters CL, Rowe CC.

Ann Neurol. 2011 Jan;69(1):181-92. doi: 10.1002/ana.22248.

3.

PET imaging of amyloid deposition in patients with mild cognitive impairment.

Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, Långström B, Nordberg A.

Neurobiol Aging. 2008 Oct;29(10):1456-65. Epub 2007 May 11.

PMID:
17499392
4.

Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.

Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ.

Arch Neurol. 2012 Feb;69(2):223-9. doi: 10.1001/archneurol.2011.666.

5.

Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.

Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Research Group.

Ann Neurol. 2010 Mar;67(3):317-24. doi: 10.1002/ana.21955.

PMID:
20373343
6.

Memory performance is related to amyloid and tau pathology in the hippocampus.

Reitz C, Honig L, Vonsattel JP, Tang MX, Mayeux R.

J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):715-21. doi: 10.1136/jnnp.2008.154146. Epub 2009 Mar 3.

7.

Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.

Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC.

JAMA Neurol. 2013 Jul;70(7):903-11. doi: 10.1001/jamaneurol.2013.1062.

PMID:
23712469
8.

Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study.

Pike KE, Ellis KA, Villemagne VL, Good N, Chételat G, Ames D, Szoeke C, Laws SM, Verdile G, Martins RN, Masters CL, Rowe CC.

Neuropsychologia. 2011 Jul;49(9):2384-90. doi: 10.1016/j.neuropsychologia.2011.04.012. Epub 2011 Apr 16.

PMID:
21529702
9.

Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease.

Solé-Padullés C, Bartrés-Faz D, Junqué C, Vendrell P, Rami L, Clemente IC, Bosch B, Villar A, Bargalló N, Jurado MA, Barrios M, Molinuevo JL.

Neurobiol Aging. 2009 Jul;30(7):1114-24. Epub 2007 Nov 28.

PMID:
18053618
10.

Association of gray matter atrophy with age, β-amyloid, and cognition in aging.

Oh H, Madison C, Villeneuve S, Markley C, Jagust WJ.

Cereb Cortex. 2014 Jun;24(6):1609-18. doi: 10.1093/cercor/bht017. Epub 2013 Feb 6.

11.

Frequent amyloid deposition without significant cognitive impairment among the elderly.

Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE.

Arch Neurol. 2008 Nov;65(11):1509-17. doi: 10.1001/archneur.65.11.1509.

12.

β-Amyloid affects frontal and posterior brain networks in normal aging.

Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust WJ.

Neuroimage. 2011 Feb 1;54(3):1887-95. doi: 10.1016/j.neuroimage.2010.10.027. Epub 2010 Oct 18.

13.

Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.

Kantarci K, Lowe V, Przybelski SA, Senjem ML, Weigand SD, Ivnik RJ, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr.

Neurology. 2011 Sep 6;77(10):951-8. doi: 10.1212/WNL.0b013e31822dc7e1. Epub 2011 Aug 24.

14.

Face-name associative memory performance is related to amyloid burden in normal elderly.

Rentz DM, Amariglio RE, Becker JA, Frey M, Olson LE, Frishe K, Carmasin J, Maye JE, Johnson KA, Sperling RA.

Neuropsychologia. 2011 Jul;49(9):2776-83. doi: 10.1016/j.neuropsychologia.2011.06.006. Epub 2011 Jun 12.

15.

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC.

Brain. 2007 Nov;130(Pt 11):2837-44. Epub 2007 Oct 10.

PMID:
17928318
16.

Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.

Amieva H, Le Goff M, Millet X, Orgogozo JM, Pérès K, Barberger-Gateau P, Jacqmin-Gadda H, Dartigues JF.

Ann Neurol. 2008 Nov;64(5):492-8. doi: 10.1002/ana.21509.

PMID:
19067364
17.

Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve.

Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL.

Arch Neurol. 2008 Jan;65(1):113-20. doi: 10.1001/archneurol.2007.27.

PMID:
18195148
18.

Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities.

Nebes RD, Snitz BE, Cohen AD, Aizenstein HJ, Saxton JA, Halligan EM, Mathis CA, Price JC, Kamboh MI, Weissfeld LA, Klunk WE.

Neuropsychologia. 2013 Sep;51(11):2202-9. doi: 10.1016/j.neuropsychologia.2013.07.017. Epub 2013 Aug 1.

19.

Meta-analysis of amyloid-cognition relations in cognitively normal older adults.

Hedden T, Oh H, Younger AP, Patel TA.

Neurology. 2013 Apr 2;80(14):1341-8. doi: 10.1212/WNL.0b013e31828ab35d.

20.

The emergence of cognitive discrepancies in preclinical Alzheimer's disease: a six-year case study.

Jacobson MW, Delis DC, Peavy GM, Wetter SR, Bigler ED, Abildskov TJ, Bondi MW, Salmon DP.

Neurocase. 2009 Aug;15(4):278-93. doi: 10.1080/13554790902729465. Epub 2009 Apr 21.

Supplemental Content

Support Center